Lupin Ltd KYS Report: Ownership & Insights | Research 360

15:59 Feb 04

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2195.20

+9.30 (+0.43%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Feb 04

2195.20

+9.30 (+0.43%)

68/100 High Financial Strength

Quality

42/100 Mid Valuation

Valuation

61/100 Technically Moderately Bullish

Technical

SWOT

Strength

0

Weakness

0

Opportunity

0

Threat

0

1.00L

Market Cap (Cr)

-

PE Ratio

5.11

Price to Book Ratio

RSI

14.45 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password